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HERV-K and HERV-W transcriptional activity 
in myalgic encephalomyelitis/chronic fatigue 
syndrome
Lucas S. Rodrigues1†, Luiz H. da Silva Nali1,2†, Cibele O. D. Leal1, Ester C. Sabino1,3, Eliana M. Lacerda4, 
Caroline C. Kingdon4, Luis Nacul4 and Camila M. Romano1,5* 
Abstract 
Background: Chronic fatigue syndrome/myalgic encephalomyelitis (CFS/MS) is an incapacitating chronic disease 
that dramatically compromise the life quality. The CFS/ME pathogenesis is multifactorial, and it is believed that immu-
nological, metabolic and environmental factors play a role. It is well documented an increased activity of Human 
endogenous retroviruses (HERVs) from different families in autoimmune and neurological diseases, making these 
elements good candidates for biomarkers or even triggers for such diseases.
Methods: Here the expression of Endogenous retroviruses K and W (HERV-K and HERV-W) was determined in blood 
from moderately and severely affected ME/CFS patients through real time PCR.
Results: HERV-K was overexpressed only in moderately affected individuals but HERV-W showed no difference.
Conclusions: This is the first report about HERV-K differential expression in moderate ME/CFS. Although the rela-
tionship between HERVs and ME/CFS has yet to be proven, the observation of this phenomenon deserves further 
attention.
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Background
Myalgic encephalomyelitis/chronic fatigue syndrome 
(ME/CFS) is a chronic and debilitating disease with 
unknown etiology [1]. Affected individuals have com-
promised motor and cognitive capacities. There is a wide 
variation in the symptoms of this disease, which include 
joint pains, mood disturbance, and malaise and wors-
ening of symptoms following minimal physical or men-
tal exertion. More severe symptoms can be also present 
including extreme exhaustion, severe joint pains with 
no apparent cause, non-restorative sleep and a range of 
immune and neurological symptoms. These symptoms 
may lead to depression and social isolation in the per-
son with ME/CFS [1]. The pathophysiology of the ME/
CFS is not understood and there is no diagnostic bio-
marker available. There is still controversy over the eti-
ology of the disease; however, it is widely accepted that 
several immunological alterations are present in ME/
CFS patients [2]. In addition, accumulated evidence for 
an association of ME/CFS with viral infections also exists 
and many patients report the onset of their symptoms 
during or right after a flu-like illness [3]. Thereafter, an 
unusual autoimmune response against the infection 
would be responsible for the perpetuation of the ME/CFS 
symptoms. Viral participation is finally supported by the 
evidences of clinical benefit of patients treated with val-
ganciclovir [4]. Unfortunately, the absence of large cohort 
studies that investigate at the molecular level the partici-
pation of infectious agents on the ME/CFS pathogenesis 
impairs our understanding of this disease.
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Human endogenous retroviruses (HERVs) are derived 
from exogenous retroviral infections, which occurred 
early in the evolution of vertebrates. Due to active rep-
lication and transposition events, HERVs are extensively 
distributed through the host genome and constitute 
about 8% of the human genome [5]. Due to accumu-
lated mutations over the primate and human evolution, 
most HERVs are non-functional, but intact open read-
ing frames of some HERVs persist and can be reactivated 
in response to systemic and environmental factors such 
as hormones, stress, and infection by exogenous viruses 
including almost all human herpesviruses, HIV and oth-
ers [6, 7]. Given their potential pathogenic effects, which 
include molecular mimicry and immune deregulation, 
HERVs are often postulated as possible causes of autoim-
mune diseases. Among the more than 30 families, the K 
and W families are the most recently integrated, the most 
active, and have been frequently associated with neuro-
logical and autoimmune diseases such as multiple scle-
rosis, diabetes mellitus, systemic lupus erythematosus, 
amyotrophic lateral sclerosis and rheumatoid arthritis 
[8].
To our knowledge, only two studies have investigated 
the participation of endogenous retroviruses in ME/CFS 
with contrasting results [9, 10].
Given the extensively described altered patterns of 
HERVs in several diseases and the gap in knowledge of its 
expression in ME/CFS, we investigated the expression of 
the HERVs K and W in patients diagnosed with ME/CFS.
Methods
Participants
We used PBMC samples from a hundred patients diag-
nosed with ME/CFS and stored in the UK ME/CFS 
Biobank (UKMEB) at the London School of Hygiene and 
Tropical Medicine in this study. The UKMEB is among 
the few biorepositories worldwide with advanced storage 
and linked research infrastructure dedicated to research 
into ME/CFS [11]. Seventy-five samples were requested 
from participants diagnosed with moderate fatigue (ME/
CFSm), and 25 from participants with severe fatigue 
(ME/CFSs). Participants with ME/CFS were defined as 
moderate or severely affected based on their mobility: 
those described as severely affected were house-bound 
or bed-bound, while those described as having mild/
moderate ME/CFS were ambulatory [11]. Samples from 
70 healthy controls (also provided by the UKMEB) were 
included.
RNA extraction and real time PCR
RNA extraction from the PBMC samples was performed 
by the Trizol–chloroform method, with 1 ml Trizol and 
subsequent addition of chloroform to solubilize lipids 
allowing its removal. The samples were centrifuged at 
15,000  rpm for 15  min and the upper phase containing 
the RNA was further used. The material was precipitated 
with Isopropanol 100% and washed with 75% ethanol. In 
both steps the material was centrifuged at 15,000 rpm 
for 10  min at 4  °C. After this process, the pellets were 
dried at room temperature for 10 min, and the RNA was 
eluted in 45 μl of nuclease-free  H2O. The decontamina-
tion of remnant DNA was performed using two rounds 
DNAse treatment (Turbo DNA-Free (Ambion) follow-
ing the manufacturer’s instruction. The absence of DNA 
was confirmed by real time PCR without reverse tran-
scriptase using primers for HERV-K or HERV-W (see 
primers description below).
After this procedure, cDNA was synthesized using the 
High capacity cDNA Reverse Transcription kit (Ambion, 
USA) according the manufacturer’s instructions. Real-
time PCRs were performed for the HERV-W, -K and 
the endogenous gene using the primers and conditions 
used previously by Nali et al. [12] using the Sybr Green 
method. The primers used are described in Table 1.
The cycling conditions for both HERVs detection were: 
50 °C for 2 min, 95 °C for 10 min, followed by 40 cycles 
of 95 °C for 15 s, 50 °C for 1 min, 60 °C for 1 min. HERV 
activity was qualitatively (referred as presence/absence) 
and quantitatively (level of expression) evaluated. As 
positive controls we used a plasmid containing both 
HERV-W envelope and HERV-K polymerase fragments 
correspondent to the region covered by the primers used. 
The level of expression was determined by calculation of 
 2−ΔΔCt, and the results were represented as fold changes. 
Statistical analysis was performed using the Wilcox test 
in the GraphPad Prism program v.6.04.
Samples were only considered positive for HERVs and 
included in the analyses if expression of the endogenous 
control was also detected.
Table 1 Primers used in real-time PCR assays
Oligo Sense Antisense
HERV-W CCA ATG CAT CAG GTG GGT AAC GAG GTA CCA CAG ACA AAA AAT ATT CCT 
HERV-K TCC CCT TGG AAT ACT CCT GTTTT CAT TCC TTG TGG TAA AAC TTT CCA 
GAPDH ACC CAC TCC TCC ACC TTT GAC TGT TGC TGT AGC CAA ATT CGTT 
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Results
General description of individuals included in the study 
is described in Table 2. As expected, women were 4 times 
more prevalent than men. There were no statistically 
significant age differences among the groups (p = 0.927, 
corrected Pearson’s Chi square). Therefore, we adjusted 
the control group to the same gender prevalence. 
HERV-K and W expression were evaluated in ME/CFS 
patients and healthy controls; and some level of expres-
sion of HERV-W was detected in all patients with severe 
fatigue and in 72/75 ME/CFSm (96%). HERV-K was also 
detected in all severe cases but in 65/75 of moderate 
cases (86.6%). The healthy control group was very simi-
lar to the moderate group, with 68/70 (97%) and 60/70 
(85.7%) presenting expression of HERV-W and HERV-K 
respectively (Table  2). Only one patient with moderate 
fatigue and one control individual had no HERV activity 
at all. No relation was observed regarding HERV detec-
tion and duration of disease.
Regarding to the level of expression (quantitative 
analysis), real time results revealed that HERV-W did 
not present significant differences when the healthy 
controls (HCs) or the two ME/CFS groups were com-
pared between each other (Fig. 1a), i.e. ME/CFSs vs HCs 
(p = 0.89), ME/CFSm vs HCs (p = 0.77), ME/CFSs vs ME/
CFSm (p = 0.95), all patients ME/CFS vs HCs (p = 0.78).
On the other hand, the HERV-K expression differed 
significantly between ME/CFSm group and the HCs 
(p = 0.050). HERV-K activity was not distinct between 
the ME/CFS groups: ME/CFSs vs ME/CFSm (p = 0.12), 
ME/CFS vs HCs (p = 0.17). ME/CFSs vs HCs (p = 0.97) 
(Fig. 1b).
Discussion
The most recognized and widely-used case definitions 
(Fukuda [13] and Canadian Consensus criteria [1]) are 
based on self-reported symptoms. Studies of energy 
metabolism, oxidative stress and immunological altera-
tions in ME/CFS have demonstrated imbalance in all 
these pathways, but the use of such information for diag-
nostic purposes is still far from reality.
Here, HERV-K and W transcripts were detected in 
all groups investigated, and we found that HERV-K was 
overexpressed in moderate ME/CFS. It is possible that 
the immunological, genic expression and metabolic alter-
ations are different according to disease severity.
The interplay between endogenous retroviruses and 
the immune system is complex. ERVs are part of the host 
genome and in theory, they are supposed to be recog-
nized as self-antigens and an immune tolerance should 
be established during the early stages of the organism 
development [14]. However, HERV products can interact 
with components of the innate immune system leading to 
the activation of pro-inflammatory pathways or, in some 
particular cases, their suppression [15]. The syncytin-2 
protein for example, is a product of the ERV-FRD Env 
gene that has an immunosuppressive role by prevent-
ing maternal immune response against the fetus [16]. In 
a distinct scenario, it was demonstrated using psoriasis 
model that a pro-inflammatory environment could be 
able to suppress the expression of repetitive elements, 
including HERVs [17]. It would be reasonable to sug-
gest that the immunological enhancement seen in more 
severe ME/CFS works by silencing the HERV transacti-
vation that occurs in moderate cases. Such transactiva-
tion could be caused by exogenous viral replication or 
another as yet unknown factor. In line with this, Montoya 
and colleagues found a cytokine signature of severity in 
people with ME/CFS [18]. They demonstrated that from 
the 17 cytokines related to severity, 13 are pro-inflam-
matory, and (in addition to the worsening of the symp-
toms) may cause the reversion of the HERV-K activity to 
levels similar to those seen in healthy individuals. It may 
similarly occur with HERV-W, which, despite not being 
at significant levels, there was a slight decrease in people 
severely affected by ME/CFS when compared to those 
who are moderately affected.
Infection has often been considered as a trigger to ME/
CFS. Many patients report that the fatigue began during 
or short after an episode of infectious disease. A number 
of pathogens including viruses have been associated with 
this disease [3]. And, due to its life long persistence and 
Table 2 Main characteristics of individuals included in the study
a Qualitatively
Participants (#) Age
Median (max, min)
Gender (%) Time of disease
Median (max, min)
Detection of HERV 
 activitya
M F HK HW
ME/CFSs (25) 49.7 (22–59) 24% 76% 15.3 (2.8–40) 100% 100%
ME/CFSm (75) 43.5 (18–60) 25.4% 74.6% 9.5 (0.2–33.7) 86.6% 96%
Controls (70) 43.8 (18–60) 25.7% 74.3% − 85.7% 97%
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broad cell tropism, the herpesviridae family, particularly 
HHV-6 has been considered to be a possible trigger for 
ME/CFS for many, even though such relationship has 
not been consistent [3, 9]. Interestingly, HHV-6 as some 
other herpesviruses, is also capable of transactivating 
HERVs, particularly, HERV-K [6]. Such transactivation 
may be either direct (through LTR activation by viral 
products) or indirect (via transcriptional binding fac-
tors and cytokines produced by viral replication) [3, 6]. 
It is possible that as the disease progresses, whatever the 
exogenous infection that would have act as the trigger 
factor is controlled, and consequently, the HERVs trans-
activation decrease. Unfortunately, we did not perform 
serological or molecular tests for exogenous viruses.
Two reports of HERV activity in ME/CFS were pub-
lished some years ago but the results were conflicting. 
In 2013 Oakes and his team found no difference on the 
expression of HERV-K18 envelope in people with ME/
CFS when compared with HCs [9]. In the same year 
De Meirleir and colleagues, using immunohistochemi-
cal methods, found immunoreactivity to HERV pro-
teins (HERV-K, HERV-18, HERV-R and HERV-FRD) 
in dendritic cells of the duodenum of individuals diag-
nosed with the syndrome [10], suggesting that altera-
tions in endogenous retroviruses expression pattern 
may occur in ME/CFS. The differences between the 
results of Oakes and colleagues and ours may be due 
to the methods used to detect HERV-K. While the pre-
sent work used generic primers for HERV-K that allow 
the detection of hundreds of elements from most HML 
subfamilies the Oakes team searched for the HERV-K 
18 envelope transcripts only, using a method specific to 
this particular element, while neglecting all the remain-
ing proviruses from the K family. On the other hand, 
we are unable to determine which K family proviruses 
are involved in the differential expression observed.
The molecular method used here to detect HERV-W 
was also generic and was widely used in several stud-
ies that found differential expression of this element in 
pathological conditions, including in the blood, brain 
and CSF of multiple sclerosis (MS) patients [19]. There-
fore, despite the similarity of a number of symptoms 
and the strong immunological component of ME/CFS 
Fig. 1 Boxplot of expression levels (in fold change) of HERVs among the groups. a HERV-K and b HERV-W. Significance between the groups 
(obtained by Wilcox test) is evidenced by an asterisk
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and MS, the mechanisms responsible for HERV reacti-
vation in such diseases are likely distinct.
Conclusion
In conclusion, this is the first report that demonstrates 
increased expression of an endogenous retrovirus in 
the blood of individuals with moderate ME/CFS. While 
the increased expression of these retroelements can’t be 
directly associated to the ME/CFS pathogeny, the obser-
vation of this phenomenon cannot be ignored.
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